214 related articles for article (PubMed ID: 8689906)
1. Long-term use of nonsteroidal antiinflammatory drugs and other chemopreventors and risk of subsequent colorectal neoplasia.
Peleg II; Lubin MF; Cotsonis GA; Clark WS; Wilcox CM
Dig Dis Sci; 1996 Jul; 41(7):1319-26. PubMed ID: 8689906
[TBL] [Abstract][Full Text] [Related]
2. Aspirin and nonsteroidal anti-inflammatory drug use and the risk of subsequent colorectal cancer.
Peleg II; Maibach HT; Brown SH; Wilcox CM
Arch Intern Med; 1994 Feb; 154(4):394-9. PubMed ID: 8117171
[TBL] [Abstract][Full Text] [Related]
3. Reduced incidence of colorectal adenoma among long-term users of nonsteroidal antiinflammatory drugs: a pooled analysis of published studies and a new population-based study.
García Rodríguez LA; Huerta-Alvarez C
Epidemiology; 2000 Jul; 11(4):376-81. PubMed ID: 10874542
[TBL] [Abstract][Full Text] [Related]
4. Reduced risk of colorectal cancer among long-term users of aspirin and nonaspirin nonsteroidal antiinflammatory drugs.
García-Rodríguez LA; Huerta-Alvarez C
Epidemiology; 2001 Jan; 12(1):88-93. PubMed ID: 11138826
[TBL] [Abstract][Full Text] [Related]
5. Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer.
Chan AT; Giovannucci EL; Meyerhardt JA; Schernhammer ES; Curhan GC; Fuchs CS
JAMA; 2005 Aug; 294(8):914-23. PubMed ID: 16118381
[TBL] [Abstract][Full Text] [Related]
6. Interaction of calcium supplementation and nonsteroidal anti-inflammatory drugs and the risk of colorectal adenomas.
Grau MV; Baron JA; Barry EL; Sandler RS; Haile RW; Mandel JS; Cole BF
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2353-8. PubMed ID: 16214916
[TBL] [Abstract][Full Text] [Related]
7. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
Sandler RS
Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
[TBL] [Abstract][Full Text] [Related]
8. Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study.
Grau MV; Sandler RS; McKeown-Eyssen G; Bresalier RS; Haile RW; Barry EL; Ahnen DJ; Gui J; Summers RW; Baron JA
J Natl Cancer Inst; 2009 Feb; 101(4):267-76. PubMed ID: 19211442
[TBL] [Abstract][Full Text] [Related]
9. Lifestyle-related risk factors and chemoprevention for colorectal neoplasia: experience from the large-scale NORCCAP screening trial.
Gondal G; Grotmol T; Hofstad B; Bretthauer M; Eide TJ; Hoff G
Eur J Cancer Prev; 2005 Aug; 14(4):373-9. PubMed ID: 16030428
[TBL] [Abstract][Full Text] [Related]
10. Aspirin and nonaspirin nonsteroidal antiinflammatory drug use and occurrence of colorectal adenoma in Black American women.
Barber LE; Bertrand KA; Sheehy S; White LF; Roy HK; Rosenberg L; Palmer JR; Petrick JL
Int J Cancer; 2023 Dec; 153(12):1978-1987. PubMed ID: 37555819
[TBL] [Abstract][Full Text] [Related]
11. Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysis.
Dulai PS; Singh S; Marquez E; Khera R; Prokop LJ; Limburg PJ; Gupta S; Murad MH
BMJ; 2016 Dec; 355():i6188. PubMed ID: 27919915
[TBL] [Abstract][Full Text] [Related]
12. Effect of aspirin on long-term risk of colorectal cancer: consistent evidence from randomised and observational studies.
Flossmann E; Rothwell PM;
Lancet; 2007 May; 369(9573):1603-13. PubMed ID: 17499602
[TBL] [Abstract][Full Text] [Related]
13. Differences in risk factor-colorectal adenoma associations according to non-steroidal anti-inflammatory drug use.
Mujtaba S; Bostick RM
Eur J Gastroenterol Hepatol; 2018 Nov; 30(11):1318-1326. PubMed ID: 30161027
[TBL] [Abstract][Full Text] [Related]
14. Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force.
Rostom A; Dubé C; Lewin G; Tsertsvadze A; Barrowman N; Code C; Sampson M; Moher D;
Ann Intern Med; 2007 Mar; 146(5):376-89. PubMed ID: 17339623
[TBL] [Abstract][Full Text] [Related]
15. Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drug Use and Colorectal Cancer Risk: A Population-Based, Case-Control Study.
Friis S; Riis AH; Erichsen R; Baron JA; Sørensen HT
Ann Intern Med; 2015 Sep; 163(5):347-55. PubMed ID: 26302241
[TBL] [Abstract][Full Text] [Related]
16. Colorectal cancer prevention: is an ounce of prevention worth a pound of cure?
Gill S; Sinicrope FA
Semin Oncol; 2005 Feb; 32(1):24-34. PubMed ID: 15726503
[TBL] [Abstract][Full Text] [Related]
17. PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs.
Ulrich CM; Whitton J; Yu JH; Sibert J; Sparks R; Potter JD; Bigler J
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):616-9. PubMed ID: 15767339
[TBL] [Abstract][Full Text] [Related]
18. Nonsteroidal antiinflammatory agents in chemoprevention of colorectal cancer. At what cost?
Trujillo MA; Garewal HS; Sampliner RE
Dig Dis Sci; 1994 Oct; 39(10):2260-6. PubMed ID: 7924753
[TBL] [Abstract][Full Text] [Related]
19. Aspirin and NSAIDs for the prevention of colorectal cancer.
Baron JA
Recent Results Cancer Res; 2009; 181():223-9. PubMed ID: 19213572
[TBL] [Abstract][Full Text] [Related]
20. CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk.
Bigler J; Whitton J; Lampe JW; Fosdick L; Bostick RM; Potter JD
Cancer Res; 2001 May; 61(9):3566-9. PubMed ID: 11325819
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
